S. 2512 — what changed
Adding Zika Virus to the FDA Priority Review Voucher Program Act
From Reported in Senate to Engrossed in Senate. 1 section amended between Reported in Senate and Engrossed in Senate.
Sec. 2 Expanding tropical disease product priority review voucher program to encourage treatments for Zika Virus Disease
changed
Section 524(a)(3) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360n) 360n(a)(3)) is amended—
changed
by redesignating subparagraph (R) as subparagraph (S); and(S);
added
in subparagraph (Q), by striking “Filoviruses” and inserting “Filovirus Diseases”; and
renumbered
was (4)
by inserting after subparagraph (Q) the following:
added “(R) Zika Virus Disease.”
removed
“(R) Zika virus.”